MicroRNA Expression Profiling Of Eutopic Endometrium In Women With Versus Without Endometriosis
Funder
National Health and Medical Research Council
Funding Amount
$224,211.00
Summary
Endometriosis is a medical condition where endometrium grows outside the womb. About 10% of women have this condition that can cause abdominal pain, painful periods and difficulty conceiving a child. Now endometriosis can only be diagnosed by surgical procedure. We believe that the presence of endometriosis causes particular small molecules called microRNAs to be present in the lining of the womb or in the blood only in women with endometriosis, and we could develop a test for endometriosis with ....Endometriosis is a medical condition where endometrium grows outside the womb. About 10% of women have this condition that can cause abdominal pain, painful periods and difficulty conceiving a child. Now endometriosis can only be diagnosed by surgical procedure. We believe that the presence of endometriosis causes particular small molecules called microRNAs to be present in the lining of the womb or in the blood only in women with endometriosis, and we could develop a test for endometriosis without resorting to surgery.Read moreRead less
Harnessing Systems Biology To Tackle Neglected Tropical Diseases
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Neglected tropical diseases (NTD) have a devastating, long-term impact on billions of humans globally. No vaccines are available, and mass treatment strategies are leading to drug resistance. Thus, there is a major need to develop radically new and advanced interventions. By creating substantially enhanced and automated bioinformatics tools, I will unlock the fundamental molecular biology of key NTDs to underpin the design of new drugs, vaccines and diagnostics as translational outcomes.
Large-scale Cancer Proteomic Analyses For Improved Prediction Of Drug Response, Patient Prognosis And Clinical Outcome
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Proteomics is the study of all of the proteins encoded by a genome. In this project, I will use a new database of proteomic and clinical data from up to 70,000 cancer samples, and create an approach to correlate proteomic features with drug response, patient prognosis and clinical outcome. The aim of this research will be to use proteomics to better guide treatment decisions, with the potential to significantly improve the health of people with cancer, both in Australia and globally.
System Biology Approaches To Uncovering Non-coding RNAs' Roles In Characterising Cancer Subtypes
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
I aim to investigate non-coding RNAs (ncRNAs)’ roles in cancer development, and how they characterise cancer subtypes. The outcomes of the proposed research are twofold: computational methods to stratify tumor subtypes and computational methods to identify groups of ncRNAs acting as drivers for each cancer subtype. The research outcomes will enable prediction of new patients’ cancer subtypes and contribute to the design of efficient treatment therapies.
Exploring Roles For MicroRNAs In Cancer Using Bioinformatics And Gene Expression Tools.
Funder
National Health and Medical Research Council
Funding Amount
$292,639.00
Summary
microRNAs are newly discovered chemicals that were the subject of the 2006 Nobel Prize in Medicine. These chemicals decrease the amount of specific molecular ‘targets’ in cells, and play an important role in cancer. Currently we do not understand how these chemicals choose their targets, and we propose to use a computer-based approach to discover how they affect genes in cancer. This will improve our understanding of cancer and thereby lead to the discovery of novel anti-cancer therapies.
Localising Epileptic Discharges In The Brain Using Non-invasive Electro-magnetic Signal Analysis In Patients With Difficult-to-control Epilepsy
Funder
National Health and Medical Research Council
Funding Amount
$179,782.00
Summary
Epilepsy is a leading cause of chronic morbidity in Australia. A fundamental problem in clinical practice is the accurate identification of the 'hotspot' zone in the brain that is generating epileptic discharges. These discharges can be detected non-invasively (over the scalp) and analysed with electro-encephalographic and magneto-encephalographic source localisation (EMSL) techniques. EMSL is not used in routine clinical practice because we await a large scale prospective study (the aim of this ....Epilepsy is a leading cause of chronic morbidity in Australia. A fundamental problem in clinical practice is the accurate identification of the 'hotspot' zone in the brain that is generating epileptic discharges. These discharges can be detected non-invasively (over the scalp) and analysed with electro-encephalographic and magneto-encephalographic source localisation (EMSL) techniques. EMSL is not used in routine clinical practice because we await a large scale prospective study (the aim of this proposal).Read moreRead less